103 related articles for article (PubMed ID: 9143410)
1. Interactions of lymphokine-activated killer cells and A549 lung carcinoma nodules maintained in three-dimensional culture.
Gharib M; Tamboise E; Tamboise A; Lièvre N; Vérola O; Beaupain R
Tumour Biol; 1997; 18(3):135-45. PubMed ID: 9143410
[TBL] [Abstract][Full Text] [Related]
2. Effects of lymphokine-activated killer-cells on melanoma nodules maintained in 3-dimensional culture.
Gharib M; Tamboise E; Tamboise A; Lievre N; Verola O; Beaupain R
Int J Oncol; 1995 Dec; 7(6):1327-32. PubMed ID: 21552968
[TBL] [Abstract][Full Text] [Related]
3. Lymphokine-activated killer cells induce differentiation in MCF-7 breast carcinoma nodules but not in mastosis nodules maintained in three-dimensional culture.
Gharib M; Mainguené C; Tamboise E; Tamboise A; Beaupain R
Tumour Biol; 1994; 15(2):90-100. PubMed ID: 8184257
[TBL] [Abstract][Full Text] [Related]
4. [Effects of LAK cells activated by IL-2 on MCF-7 human breast cancer cell line maintained in organotypic culture].
Gharib M; Mainguené C; Tamboise E; Tamboise A; Lièvre N; Amouroux J; Beaupain R
Bull Cancer; 1993 Aug; 80(8):659-65. PubMed ID: 8204946
[TBL] [Abstract][Full Text] [Related]
5. Secretion of mucoid material by lymphokine-activated killer cells: study by light and electron microscopy.
Ginsburg H; Coleman R; Davidson S; Yahav H; Khoury C
J Leukoc Biol; 1990 May; 47(5):393-408. PubMed ID: 2186162
[TBL] [Abstract][Full Text] [Related]
6. Regulation of lymphokine-activated killer cell induction by human recombinant IL-1 receptor antagonist. Obligate paracrine pathway of IL-1 during lymphokine-activated killer cell induction.
Fujiwara T; Grimm EA
J Immunol; 1992 May; 148(9):2941-6. PubMed ID: 1374105
[TBL] [Abstract][Full Text] [Related]
7. [Electron microscopic observation on the killing of human lung carcinoma cells by lymphokine-activated killer cells (LAK cells) in vitro].
Shi J
Zhonghua Yi Xue Za Zhi; 1990 Jun; 70(6):319-21, 22. PubMed ID: 2169980
[TBL] [Abstract][Full Text] [Related]
8. Functional interactions between interleukin-4, interleukin-2, and tumor necrosis factor-alpha for lymphokine-activated killer cell generation.
Blay JY; Branellec D; Robinet E; Gay F; Chouaib S
J Clin Lab Anal; 1990; 4(1):54-8. PubMed ID: 2313467
[TBL] [Abstract][Full Text] [Related]
9. In vitro development of lymphocytes that function as progenitors for mucus-secreting lymphokine-activated killer (LAK) cells.
Ginsburg H
J Leukoc Biol; 1992 Apr; 51(4):307-15. PubMed ID: 1564395
[TBL] [Abstract][Full Text] [Related]
10. Effect of TNF-alpha and IFN-alpha on the proliferation and cytotoxicity of lymphokine-activated killer cells in patients with bladder cancer.
Wang Z; Cheng Y; Zheng R; Qin D; Liu G
Chin Med J (Engl); 1997 Mar; 110(3):180-3. PubMed ID: 9594335
[TBL] [Abstract][Full Text] [Related]
11. Effects of tumour necrosis factor-alpha (TNF-alpha), IL-1 beta and monocytes on lymphokine-activated killer (LAK) induction from natural killer (NK) cells and T lymphocytes.
Yoneda K; Osaki T; Yamamoto T; Ueta E
Clin Exp Immunol; 1993 Aug; 93(2):229-36. PubMed ID: 8348749
[TBL] [Abstract][Full Text] [Related]
12. Cytokines secreted by lymphokine-activated killer cells induce endogenous nitric oxide synthesis and apoptosis in DLD-1 colon cancer cells.
Kwak JY; Han MK; Choi KS; Park IH; Park SY; Sohn MH; Kim UH; McGregor JR; Samlowski WE; Yim CY
Cell Immunol; 2000 Aug; 203(2):84-94. PubMed ID: 11006006
[TBL] [Abstract][Full Text] [Related]
13. Interaction between lymphokine activated killer cells generated in the presence of cisplatin/FK-565 and tumor cells: transmission electron microscopy analysis.
Basu S; Sodhi A
Anticancer Drugs; 1992 Apr; 3(2):155-62. PubMed ID: 1525394
[TBL] [Abstract][Full Text] [Related]
14. In vivo treatment with interferon causes augmentation of IL-2 induced lymphokine-activated killer cells in the organs of mice.
Puri RK; Leland P
Clin Exp Immunol; 1991 Aug; 85(2):317-25. PubMed ID: 1713814
[TBL] [Abstract][Full Text] [Related]
15. The role of lymphotoxin in the IL-2-driven differentiation of human lymphokine-activated T-killer (T-LAK) cells in vitro.
Abe Y; Van Eden M; Gatanaga M; Wang FI; Brightbill HD; Granger GA; Gatanaga T
Lymphokine Cytokine Res; 1993 Oct; 12(5):279-83. PubMed ID: 8260536
[TBL] [Abstract][Full Text] [Related]
16. Lysis of autologous human macrophages by lymphokine-activated killer cells: interaction of effector cell and target cell conjugates analyzed by scanning electron microscopy.
Streck RJ; Helinski EH; Ovak GM; Pauly JL
J Leukoc Biol; 1990 Sep; 48(3):237-46. PubMed ID: 2391448
[TBL] [Abstract][Full Text] [Related]
17. Generation of a small cell lung cancer variant resistant to lymphokine-activated killer (LAK) cells: association with resistance to a LAK cell-derived, cytostatic factor.
Tachibana I; Watanabe M; Tanio Y; Hayashi S; Hosoe S; Saito S; Matsunashi M; Osaki T; Shigedo Y; Masuno T
Cancer Res; 1992 Jun; 52(12):3310-6. PubMed ID: 1350752
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary surfactant inhibits interleukin-2-induced proliferation and the generation of lymphokine-activated killer cells.
Roth MD; Pinto M; Golub SH; Shau H
Am J Respir Cell Mol Biol; 1993 Dec; 9(6):652-8. PubMed ID: 8257596
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-2 modulates the expression of lymphocyte function-associated antigen-one (LFA-1) and p150,95 during the generation of lymphokine-activated killer (LAK) cells.
Grant AJ; Merchant RE; Hall RE
Immunology; 1989 Jan; 66(1):117-24. PubMed ID: 15493273
[TBL] [Abstract][Full Text] [Related]
20. Inhibition by fibrin coagulation of lung cancer cell destruction by human interleukin-2-activated killer cells.
Atagi S; Sone S; Fukuta K; Ogura T
Jpn J Cancer Res; 1992 Oct; 83(10):1088-94. PubMed ID: 1452461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
